VentriPoint Diagnostics Ltd.
VPTDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,764 | $21,490 | $28,605 | $15,707 |
| - Cash | $49 | $249 | $353 | $61 |
| + Debt | $2,349 | $2,217 | $2,128 | $1,635 |
| Enterprise Value | $18,063 | $23,458 | $30,380 | $17,281 |
| Revenue | $104 | $0 | $71 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $104 | -$11 | $71 | $0 |
| % Margin | 100% | – | 100% | – |
| EBITDA | -$617 | -$1,152 | -$835 | -$1,058 |
| % Margin | -591.1% | – | -1,170.5% | – |
| Net Income | -$752 | -$1,289 | -$960 | -$1,060 |
| % Margin | -721.1% | – | -1,345.7% | – |
| EPS Diluted | -0.003 | -0.008 | -0.006 | -0.007 |
| % Growth | 59.5% | -33.9% | 10.6% | – |
| Operating Cash Flow | -$69 | -$547 | -$313 | -$721 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$69 | -$547 | -$313 | -$721 |